G Medical Innovations Holdings (G Medical Innovations Holdings) COGS-to-Revenue : -1.60 (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings COGS-to-Revenue?

G Medical Innovations Holdings's Cost of Goods Sold for the six months ended in Dec. 2022 was $-3.51 Mil. Its Revenue for the six months ended in Dec. 2022 was $2.20 Mil.

G Medical Innovations Holdings's COGS to Revenue for the six months ended in Dec. 2022 was -1.60.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. G Medical Innovations Holdings's Gross Margin % for the six months ended in Dec. 2022 was 259.61%.

G Medical Innovations Holdings COGS-to-Revenue Historical Data

The historical data trend for G Medical Innovations Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings COGS-to-Revenue Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

1.32

1.04

0.86

0.70

0.82

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
COGS-to-Revenue	Get a 7-Day Free Trial							0.59	0.61	0.82	3.21	-1.60

G Medical Innovations Holdings COGS-to-Revenue Calculation

G Medical Innovations Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.636	/	4.42
	=	0.82

G Medical Innovations Holdings's COGS to Revenue for the quarter that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	-3.505	/	2.196
	=	-1.60

G Medical Innovations Holdings (OTCPK:GMVDF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

G Medical Innovations Holdings's Gross Margin % for the six months ended in Dec. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	-3.505 / 2.196
	=	259.61 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

G Medical Innovations Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022